Back
AbbVie Stock Price Chart
Sponsored
ABBV
Sponsored
My #1 Coin is...
All the details are on the next page.
Sell
50
ABBV
AbbVie
Last Price:
167.55
Seasonality Move:
2.71%
7 Day Trial
ALL ACCESS PASS
$
7
BREAKING: Elon Musk's Secret A.I. Project Set to Plunge Millions of Americans Into Poverty
Click here now to prepare yourself for what's around the corner- Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ABBV is experiencing slight selling pressure.
AbbVie Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 165.6 | Buy |
20-day SMA: | 170.13 | Sell |
50-day SMA: | 174.9 | Sell |
200-day SMA: | 156.53 | Buy |
8-day EMA: | 167.19 | Buy |
20-day EMA: | 169.35 | Sell |
50-day EMA: | 170.94 | Sell |
200-day EMA: | 160.67 | Buy |
AbbVie Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -2.56 | Sell |
Relative Strength Index (14 RSI): | 44.01 | Sell |
Chaikin Money Flow: | -419205 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (165.16 - 178.24) | Sell |
Bollinger Bands (100): | (156.67 - 177.81) | Buy |
AbbVie Technical Analysis
Apr 11 | Apr 12 | Apr 15 | Apr 16 | Apr 17 | Apr 18 | Apr 19 | Apr 22 | Apr 23 | Apr 24 | |
---|---|---|---|---|---|---|---|---|---|---|
Apr | ||||||||||
11 | 12 | 15 | 16 | 17 | 18 | 19 | 22 | 23 | 24 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for AbbVie Stock
Is AbbVie Stock a Buy?
- AbbVie share price is 167.80 while ABBV 8-day simple moving average is 165.60, which is a Buy signal.
- The stock price of ABBV is 167.80 while AbbVie 20-day SMA is 170.13, which makes it a Sell.
- AbbVie 50-day simple moving average is 174.90 while ABBV share price is 167.80, making it a Sell technically.
- ABBV stock price is 167.80 and AbbVie 200-day simple moving average is 156.53, creating a Buy signal.
ABBV Technical Analysis vs Fundamental Analysis
AbbVie Stock Info
Market Cap:
296.41B
Price in USD:
167.80
Share Volume:
3.97M
AbbVie 52-Week Range
52-Week High:
182.89
52-Week Low:
130.96
Sell
50
AbbVie (ABBV)
is a Sell
AbbVie Share Price Forecast
-
What is the AbbVie stock price today?
The AbbVie stock price is 167.80 USD today. -
Will ABBV stock go up or go down?
AbbVie> share price is forecast to RISE/FALL based on technical indicators -
Is AbbVie overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, AbbVie is overvalued.
Is AbbVie Stock a Buy?
- AbbVie share price is 167.80 while ABBV 8-day exponential moving average is 167.19, which is a Buy signal.
- The stock price of ABBV is 167.80 while AbbVie 20-day EMA is 169.35, which makes it a Sell.
- AbbVie 50-day exponential moving average is 170.94 while ABBV share price is 167.80, making it a Sell technically.
- ABBV stock price is 167.80 and AbbVie 200-day simple moving average is 160.67, creating a Buy signal.
Fundamental Analysis of AbbVie
Is AbbVie a good investment?
- Analysts estimate an earnings increase this quarter of $0.08 per share, a decrease next quarter of $0.19 per share, an increase this year of $0.03 per share, and an increase next year of $0.96 per share.
Technical Analysis of AbbVie
Should I short AbbVie stock?
- ABBV Moving Average Covergence Divergence (MACD) indicator is -2.56, suggesting AbbVie is a Sell
- AbbVie Relative Strength Index (RSI) is 44.01, which suggest AbbVie is oversold
- The Bollinger Bands (25) for AbbVie is (165.16 - 178.24), which suggest AbbVie is a Buy
- The Bollinger Bands (100) for AbbVie is (156.67 - 177.81), which suggest AbbVie is a Buy
* AbbVie stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.